GPCR crystal structures: Medicinal chemistry in the pocket

被引:87
作者
Shonberg, Jeremy [1 ]
Kling, Ralf C. [1 ]
Gmeiner, Peter [1 ]
Loeber, Stefan [1 ]
机构
[1] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91052 Erlangen, Germany
关键词
GPCR; Medicinal chemistry; Crystal structure; Drug discovery; Receptor activation; Ligand-receptor interactions; Receptor selectivity; PROTEIN-COUPLED RECEPTORS; NOCICEPTIN/ORPHANIN FQ RECEPTOR; BETA-ADRENOCEPTOR AGONISTS; STRUCTURE-BASED DISCOVERY; DOPAMINE D3 RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; OPIOID RECEPTOR; SMALL-MOLECULE; IN-VITRO; ALLOSTERIC MODULATORS;
D O I
10.1016/j.bmc.2014.12.034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent breakthroughs in GPCR structural biology have significantly increased our understanding of drug action at these therapeutically relevant receptors, and this will undoubtedly lead to the design of better therapeutics. In recent years, crystal structures of GPCRs from classes A, B, C and F have been solved, unveiling a precise snapshot of ligand-receptor interactions. Furthermore, some receptors have been crystallized in different functional states in complex with antagonists, partial agonists, full agonists, biased agonists and allosteric modulators, providing further insight into the mechanisms of ligand-induced GPCR activation. It is now obvious that there is enormous diversity in the size, shape and position of the ligand binding pockets in GPCRs. In this review, we summarise the current state of solved GPCR structures, with a particular focus on ligand-receptor interactions in the binding pocket, and how this can contribute to the design of GPCR ligands with better affinity, subtype selectivity or efficacy. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3880 / 3906
页数:27
相关论文
共 247 条
[51]   In Silico screening for agonists and blockers of the β2 adrenergic receptor: Implications of inactive and activated state structures [J].
Costanzi, Stefano ;
Vilar, Santiago .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2012, 33 (05) :561-572
[52]   Thrombin signalling and protease-activated receptors [J].
Coughlin, SR .
NATURE, 2000, 407 (6801) :258-264
[53]   Highlights on the development of A2A adenosine receptor agonists and antagonists [J].
Cristalli, Gloria ;
Cacciari, Barbara ;
Dal Ben, Diego ;
Lambertucci, Catia ;
Moro, Stefano ;
Spalluto, Giampiero ;
Volpini, Rosaria .
CHEMMEDCHEM, 2007, 2 (03) :260-281
[54]   BINDING OF ANTIDEPRESSANTS TO HUMAN BRAIN RECEPTORS - FOCUS ON NEWER GENERATION COMPOUNDS [J].
CUSACK, B ;
NELSON, A ;
RICHELSON, E .
PSYCHOPHARMACOLOGY, 1994, 114 (04) :559-565
[55]  
DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999
[56]   Sphingosine 1-phosphate analogs as receptor antagonists [J].
Davis, MD ;
Clemens, JJ ;
Macdonald, TL ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (11) :9833-9841
[57]   New approaches toward anti-HIV chemotherapy [J].
De Clercq, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) :1297-1313
[58]   Selective structure-based virtual screening for full and partial agonists of the β2 adrenergic receptor [J].
de Graaf, Chris ;
Rognan, Didier .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) :4978-4985
[59]   Crystal Structure-Based Virtual Screening for Fragment-like Ligands of the Human Histamine H1 Receptor [J].
de Graaf, Chris ;
Kooistra, Albert J. ;
Vischer, Henry F. ;
Katritch, Vsevolod ;
Kuijer, Martien ;
Shiroishi, Mitsunori ;
Iwata, So ;
Shimamura, Tatsuro ;
Stevens, Raymond C. ;
de Esch, Iwan J. P. ;
Leurs, Rob .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (23) :8195-8206
[60]   Identification of a major co-receptor for primary isolates of HIV-1 [J].
Deng, HK ;
Liu, R ;
Ellmeier, W ;
Choe, S ;
Unutmaz, D ;
Burkhart, M ;
DiMarzio, P ;
Marmon, S ;
Sutton, RE ;
Hill, CM ;
Davis, CB ;
Peiper, SC ;
Schall, TJ ;
Littman, DR ;
Landau, NR .
NATURE, 1996, 381 (6584) :661-666